Glycosylated Nanoparticles as Efficient Antimicrobial Delivery Agents.

Area of Science:

• Polymer Chemistry
• Nanotechnology
• Materials Science

Background:

• Synthetic polymer nanoparticles offer a versatile platform for drug delivery.
• Tailoring nanoparticle surfaces with specific ligands enhances targeting and efficacy.
• Encapsulating bioactive molecules within nanoparticles protects them and controls release.

Purpose of the Study:

• To develop glycosylated nanoparticles (glyco-NPs) for targeted antibiotic delivery.
• To investigate the encapsulation and release of ampicillin from these glyco-NPs.
• To evaluate the antibacterial efficacy of ampicillin-loaded glyco-NPs against Staphylococcus aureus and Escherichia coli.

Main Methods:

• Preparation of well-defined block copolymers via RAFT polymerization.
• Postpolymerization functionalization to create amphiphilic glycopolymers.
• Nanoprecipitation to form glucosylated and galactosylated nanoparticles (Glc-NPs and Gal-NPs).
• Characterization using dynamic light scattering (DLS) and transmission electron microscopy (TEM).
• Encapsulation and release studies with ampicillin.

Main Results:

• Successfully synthesized glucosylated and galactosylated nanoparticles with controlled structures.
• Ampicillin-loaded glyco-NPs (glyconanobiotics) demonstrated the ability to aggregate bacteria.
• Glyconanobiotics exhibited antibacterial activity comparable to free ampicillin.
• Bacterial aggregation was observed for both Staphylococcus aureus and Escherichia coli.

Conclusions:

• Glyconanobiotics represent a promising strategy for localized antibiotic delivery.
• Promoting bacterial aggregation enhances antibacterial efficiency.
• This approach may allow for reduced antibiotic dosages.
• The study highlights a novel method for combating bacterial infections.